Last update 21 Dec 2024

MDC-CAR-BCMA001(Dresden University of Technology)

Overview

Basic Info

Drug Type
Autologous CAR-T
Synonyms-
Target
BCMA
Mechanism
BCMA modulators(B-cell maturation protein modulators), Immunologic cytotoxicity, T lymphocyte replacements
Therapeutic Areas
NeoplasmsImmune System DiseasesCardiovascular Diseases+ [2]
Active Indication
Diffuse large B-cell lymphoma recurrentDiffuse large B-cell lymphoma refractoryRefractory Multiple Myeloma+ [1]
Inactive Indication-
Originator Organization-
Active Organization
Dresden University of TechnologyDresden University of Technology
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with MDC-CAR-BCMA001(Dresden University of Technology)
NCT05836896 / RecruitingPhase 1
A Phase I Trial to Establish the Safety and Maximum Tolerated Dose of High-affinity Autologous BCMA-targeting CAR T-cells in Patients With Relapsed and Refractory B-cell Malignancies
100 Clinical Results associated with MDC-CAR-BCMA001(Dresden University of Technology)
Login to view more data
100 Translational Medicine associated with MDC-CAR-BCMA001(Dresden University of Technology)
Login to view more data
100 Patents (Medical) associated with MDC-CAR-BCMA001(Dresden University of Technology)
Login to view more data
100 Deals associated with MDC-CAR-BCMA001(Dresden University of Technology)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diffuse large B-cell lymphoma recurrentPhase 1
DE
Dresden University of TechnologyDresden University of Technology
15 Feb 2024
Diffuse large B-cell lymphoma refractoryPhase 1
DE
Dresden University of TechnologyDresden University of Technology
15 Feb 2024
Refractory Multiple MyelomaPhase 1
DE
Dresden University of TechnologyDresden University of Technology
15 Feb 2024
Relapse multiple myelomaPhase 1
DE
Dresden University of TechnologyDresden University of Technology
15 Feb 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free